Japan, South Korea fret as surging coronavirus undermines leaders'
support
Send a link to a friend
[December 14, 2020]
By Rocky Swift and Sangmi Cha
TOKYO/SEOUL (Reuters) - Japan and South
Korea grappled with surging coronavirus cases and growing public
frustration on Monday, with Japan suspending a contentious travel
subsidy programme and South Korea closing some schools and considering
its toughest curbs yet.
Japan reported more than 3,000 new cases on Saturday, yet another record
as winter set in, with infections worsening in Tokyo, the northern
island of Hokkaido and the city of Osaka.
But Japan, with a focus on the economic costs, has steered clear of
tough lockdowns. It tackled its first wave of infections in the spring
by asking people to refrain from going out and for businesses to close
or curtail operating hours.
The government also launched a subidy programme called "Go To Travel" to
encourage domestic tourism and support businesses but critics said
encouraging people to travel had helped spread infections.
Prime Minister Yoshihide Suga had ruled out halting the programme,
citing economic considerations, but that changed after weekend polls
showed his support being eroded over his handling of the pandemic.
The programme would be suspended nationwide for two weeks from Dec. 28,
media reported.
Across the sea in South Korea, President Moon Jae-in also faces sliding
ratings as clusters of new infections fuel criticism over what many see
as slack containment.
Moon has warned of the possibility more stringent curbs.
"Our back is against the wall," he said. "This is a crucial moment to
devote all our virus control capabilities and administrative power to
stopping the coronavirus."
South Korea reported a new daily record of 1,030 infections on Sunday, a
big worry for a country for months held up as a mitigation success story
but still a fraction of the tallies being seen in some European
countries and the United States, where vaccines are being rolled out.
Few Asian countries expect to get significant amounts of coronavirus
vaccines in coming weeks as they manage distribution schedules, allow
time to check for any inoculation side effects elsewhere or run their
own late-stage trials.
Instead, they are counting on the methods that have largely kept
infections in check for months - ahead of the curve testing, stringent
travel curbs, strict social distancing and masks.
[to top of second column]
|
People wearing protective masks, following the coronavirus disease
(COVID-19) outbreak, make their way at Shinagawa station in Tokyo,
Japan November 13, 2020. REUTERS/Kim Kyung-Hoon/File Photo
SOME GOOD NEWS
China, for instance, where the virus emerged almost a year ago, has
managed to limit new cases with tough, sweeping action.
It locked down an area of more than 250,000 people after half a
dozen cases were confirmed near the Russian border in the province
of Heilongjiang, the Associated Press reported on Monday.
Singapore, which has reported only a handful of local cases over the
past two months, said it was easing restrictions and would soon
allow up to eight people to gather. It also approved Pfizer-BioNTech's
vaccine and said it expected its first shots by the end of the
month.
New Zealand, which has been particularly successful in tackling the
pandemic, said it had agreed to open a "travel bubble" with
Australia in the first quarter of 2021.
South Korea ordered schools to close in its capital, Seoul, and
surrounding areas and warned that restrictions may be raised to the
highest Phase 3 level, which would essentially mean a lockdown for
the first time in Asia's fourth-largest economy.
Last month, the government banned year-end parties and it has ramped
up testing to more than 22,000 people a day, compared with about
16,000 a day in September.
In Japan, which is hoping to stage the postponed summer Olympics
next year, testing has remained relatively low, peaking at about
50,000 in one day recently. Testing in Tokyo, which has the capacity
for more than 60,000, is now about 9,000 a day.
"Whether a country or region is doing enough testing should be
assessed based on the positivity rate and not on the number of
tests," said Fumie Sakamoto, infection control manager at the St
Luke's International Hospital in Tokyo.
"The positivity rate for Tokyo is now over 6%, so we should be doing
a bit more testing to bring the number down."
(Reporting by Rocky Swift in Tokyo and Sangmi Cha in Seoul; Writing
by Sayantani Ghosh in Singapore; Editing by Robert Birsel)
[© 2020 Thomson Reuters. All rights
reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |